BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37851364)

  • 1. The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma.
    Luo H; Huang K; Cheng M; Long X; Zhu X; Wu M
    Aging (Albany NY); 2023 Oct; 15(20):11052-11066. PubMed ID: 37851364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
    Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
    Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
    Xu Q; Lin W; Tao C; Huang X; Li J
    Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
    Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
    Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
    Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L
    FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway.
    Shen Y; Li J; Peng D; Liao L; Chen X; Zhong W; Liu Z; Yu C; Sun Y
    Genes Dis; 2023 Sep; 10(5):2125-2136. PubMed ID: 37492722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB.
    Huang Y; Zhang Z; Tong H; Qin W; Li Q; Ma L; Ren Z; Chen W; Zhang Y; Zhong Y; Yao L; Zhou P
    J Cell Mol Med; 2024 May; 28(10):e18268. PubMed ID: 38775031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus‑mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro.
    Fan YH; Xiao B; Lv SG; Ye MH; Zhu XG; Wu MJ
    Oncol Rep; 2017 Aug; 38(2):1149-1155. PubMed ID: 28627702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CHPF modulates cell proliferation and invasion in lung cancer.
    Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J
    Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation.
    Pan QF; Ouyang WW; Zhang MQ; He S; Yang SY; Zhang J
    J Cell Commun Signal; 2023 Mar; 17(1):89-102. PubMed ID: 36042157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer.
    Yun ZY; Wu D; Wang X; Huang P; Li N
    Kaohsiung J Med Sci; 2024 Mar; 40(3):244-254. PubMed ID: 38190270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHPF Regulates the Aggressive Phenotypes of Hepatocellular Carcinoma Cells via the Modulation of the Decorin and TGF-β Pathways.
    Liu CH; Wu BR; Ho YJ; Chu YH; Hsu WC; Tseng TJ; Li JP; Liao WC
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
    Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
    Front Oncol; 2022; 12():856712. PubMed ID: 35372047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression.
    Yen HR; Liao WC; Chen CH; Su YA; Huang YW; Hsiao C; Chou YL; Chu YH; Shih PK; Liu CH
    Mol Oncol; 2024 May; ():. PubMed ID: 38770553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the correlation of glycolysis-related chondroitin polymerizing factor (
    Zhong Q; Jiang K; Zhang F; Tian Y; Gu J; Li T; Chen X; Yang J; Sun F
    Am J Cancer Res; 2023; 13(6):2213-2233. PubMed ID: 37424829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a chondroitin polymerizing factor that cooperates with chondroitin synthase for chondroitin polymerization.
    Kitagawa H; Izumikawa T; Uyama T; Sugahara K
    J Biol Chem; 2003 Jun; 278(26):23666-71. PubMed ID: 12716890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHPF promotes malignancy of breast cancer cells by modifying syndecan-4 and the tumor microenvironment.
    Liao WC; Yen HR; Chen CH; Chu YH; Song YC; Tseng TJ; Liu CH
    Am J Cancer Res; 2021; 11(3):812-826. PubMed ID: 33791155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway.
    Hou XM; Zhang T; Da Z; Wu XA
    Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.